InvestorsHub Logo
Followers 4
Posts 851
Boards Moderated 0
Alias Born 03/06/2014

Re: None

Monday, 03/27/2017 11:41:51 PM

Monday, March 27, 2017 11:41:51 PM

Post# of 1702
BLOZF up 20% today on this news:

Testing using the Cannabix Marijuana Breathalyzer Beta prototype device with human subjects after smoking THC cigarettes demonstrated the successful detection of THC, the psychoactive component of marijuana, in real-time. In addition to THC, several metabolites were identified in the breath of the human subjects including 11-hydroxy-delta-9-tetrahydrocannabinol and delta-9-carboxy-tetrahydrocannabinol, and three other cannabinoids related to cannabigerol, were confirmed by mass spectrometry after the inhalation of cannabis.

From November 2014:
http://www.innovationews.com/science/bioscience/lifeloc-technologies-moves-to-develop-technology-to-test-marijuana-impairment/

Thanks in part to a $250,000 grant from the Colorado Office of Economic Development, Lifeloc scientists have come up with a method that can not only detect the presence of Delta 9 THC in a person's exhaled breath, it can also identify the metabolite separately.

"Feasibility of detection has already been demonstrated for very low levels of delta-9-THC, cocaine, and methamphetamine."

LCTC was pretty much demonstrating this same detection over 2 years ago according to that article.

I still have a hard time grasping how BLOZF is being valued at almost twice that of LCTC.

A nice 10 for 1 (or even 20 for 1) stock split and some updates on the marijuana breathalyzer progress being made would do this stock wonders. Most investors/bloggers/news services are not even included LCTC in the race when they have proven the same detection as BLOZF but did it over 2 years ago.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LCTC News